Symposium
Rational strategies for specific treatment situations in lung cancer
Clinical
Latest evidence meets longstanding eminence
Aims : Lung cancer is a very heterogeneous group of malignancies that often presents clinicians with major challenges. This symposium focuses on four specific treatment situations in lung cancer in which the treatment strategies are still being debated. Experienced speakers will present the latest evidence and combine it with their longstanding experience to yield rational treatment strategies.
Target audience :
Allied health professional, Clinician, Fellow, General practitioner, Immunologist, Junior member, Nurse, Oncologist, Pathologist, Patient, Pulmonologist, Radiologist, Researcher, Resident, Respiratory physician, Respiratory therapist, Scientist, Student, Thoracic endoscopist, Thoracic surgeon, Trainee
08:30
Stage I NSCLC: the extent of surgical resection needed, or, better yet, radiotherapy?
P. Van Schil(Edegem (Antwerp), Belgium)
COI
-
Description
1
262
09:00
Stage IIIA/B NSCLC: rationale for multimodal diversity
W. Eberhardt(Essen, Germany)
COI
-
Description
2
263
09:30
Stage IV NSCLC, oligometastatic disease: meaningful patient selection and multimodal treatment approaches
I. Opitz(Zurich, Switzerland)
COI
-
Description
3
264
10:00
Relapsed NSCLC and SCLC: benefits and limitations of systemic treatments beyond the second line
T. Blum(Berlin, Germany)
COI
-
Description
4
265
. . .
